## Biotech Rally Continues: TELA and Peers Gain Traction on Mixed Earnings and FDA Progress
The biotech sector showed mixed momentum in Monday's after-hours session, with several therapeutic companies catching investor attention through a combination of earnings surprises, improved financial metrics, and regulatory tailwinds.
**The Standouts: Who Moved the Most**
Inotiv Inc. (NOTV) staged the most dramatic turnaround of the session, rocketing 36.61% after hours to $0.94, despite closing down 33.20% during regular trading. The sharp recovery came on the heels of the company's fourth-quarter and
The biotech sector showed mixed momentum in Monday's after-hours session, with several therapeutic companies catching investor attention through a combination of earnings surprises, improved financial metrics, and regulatory tailwinds.
**The Standouts: Who Moved the Most**
Inotiv Inc. (NOTV) staged the most dramatic turnaround of the session, rocketing 36.61% after hours to $0.94, despite closing down 33.20% during regular trading. The sharp recovery came on the heels of the company's fourth-quarter and